Becton, Dickinson and Company (BDX) Investment Research Dashboard
About Becton, Dickinson and Company (BDX) stock analysis
Get live BDX stock price $166.33, comprehensive Becton, Dickinson and Company stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time BDX stock data and investment insights.
Loading chart data...
Becton, Dickinson and Company (BDX) Overview
Becton, Dickinson and Company (BDX) is a publicly traded company in the Healthcare sector , specifically within the Medical - Instruments & Supplies industry . As of the latest trading session, BDX trades at $166.33 with a market capitalization of 60.26B . Over the past 52 weeks, BDX has traded between $127.59 and $187.35 , with the current price positioned at approximately 65% of this range . ...
Key Takeaways
- Operates in the Healthcare sector (Medical - Instruments & Supplies)
- Market cap: 60.26B
- Current price: $166.33
- 52-week range: $127.59 - $187.35
- P/E ratio: 12.37
Investment Score
A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Operating globally, Becton, Dickinson and Company (BD) is a prominent enterprise focused on the development, manufacturing, and distribution of a broad spectrum of medical technology. This includes essential medical supplies, sophisticated devices, a...
Company Information
- CEO
- Thomas E. Polen Jr.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Employees
- 72000
Contact Information
- Website
- https://www.bd.com
- Address
- 1 Becton Drive
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 12.4)
✓ Lower volatility stock (Beta: 0.27) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Becton, Dickinson and Company shareholders
- ⚠Market volatility can significantly impact stock price, especially for mid-cap stocks
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Becton, Dickinson and Company
- ⚠Investors should consider how Becton, Dickinson and Company fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
60.26B
P/E Ratio (TTM)
12.37
Beta
0.27
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare BDX with peer companies:
- Price
- $140.56+1.93% (1D)
- Market cap
- 39.70B
- Price
- $69.12+2.73% (1D)
- Market cap
- 33.71B
- Price
- $872.23-1.87% (1D)
- Market cap
- 54.24B
- Price
- $232.53+1.38% (1D)
- Market cap
- 54.46B
- Price
- $83.69+0.78% (1D)
- Market cap
- 48.19B
- Price
- $10.27+3.27% (1D)
- Market cap
- 45.23B
- Price
- $569.54+2.40% (1D)
- Market cap
- 44.93B
- Price
- $243.16+14.04% (1D)
- Market cap
- 40.58B
- Price
- $208.99+2.91% (1D)
- Market cap
- 30.31B
- Price
- $201.15+3.44% (1D)
- Market cap
- 32.68B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.
Healthcare (1D)
73/100 ⭐⭐⭐⭐⭐
- Overall
- +0.6%
- NYSE
- +0.7%
- NASDAQ
- +0.4%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Financial Services | +1.9% | +2.8% | +4.0% | 19.2 | 98/100⭐⭐⭐⭐⭐ |
| Communication Services | +1.5% | -0.5% | +3.1% | 22.3 | 74/100⭐⭐⭐⭐⭐ |
| Healthcare | +0.6% | +1.2% | +1.5% | 24.0 | 73/100⭐⭐⭐⭐⭐ |
| Basic Materials | +0.9% | +1.7% | +0.2% | 25.3 | 66/100⭐⭐⭐⭐ |
| Consumer Defensive | -0.0% | +2.0% | +0.9% | 29.8 | 63/100⭐⭐⭐⭐ |
| Real Estate | +0.4% | +0.9% | -1.6% | 29.5 | 50/100⭐⭐⭐ |
| Energy | -1.7% | -3.3% | -3.7% | 19.2 | 39/100⭐⭐ |
| Utilities | -1.1% | -0.0% | -4.5% | 26.8 | 35/100⭐⭐ |
| Industrials | +0.7% | +0.5% | -9.8% | 30.0 | 21/100⭐ |
| Technology | +0.9% | -1.3% | -6.9% | 40.9 | 18/100⭐ |
| Consumer Cyclical | +0.3% | -1.7% | -6.0% | 42.8 | 14/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-28.